Study Suggests Intracranial Pathology Not Necessary for Gadolinium Deposition in Brain Tissues
June 27, 2017
June 27, 2017
OAK BROOK, Ill., June 27 -- The Radiological Society of North America issued the following news release:
Minute traces of gadolinium, the contrast agent used to enhance MR images, are often retained in the brain tissue of patients years after undergoing MRI. Some studies have suggested this deposition was limited to patients with underlying brain pathology, such as a tumor or infection. However, new research suggests gadolinium retention may be more widespread and may be present in . . .
Minute traces of gadolinium, the contrast agent used to enhance MR images, are often retained in the brain tissue of patients years after undergoing MRI. Some studies have suggested this deposition was limited to patients with underlying brain pathology, such as a tumor or infection. However, new research suggests gadolinium retention may be more widespread and may be present in . . .